Sort by

Send to

Choose Destination

Search results

Items: 10


Epidemiology of Streptococcus pneumoniae causing acute otitis media among children in Southern Catalonia throughout 2007-2013: Incidence, serotype distribution and vaccine's effectiveness.

Ochoa-Gondar O, Figuerola-Massana E, Vila-Corcoles A, Aguirre CA, de Diego C, Satue E, Gomez F, Raga X; EPIVAC Study Group.

Int J Pediatr Otorhinolaryngol. 2015 Dec;79(12):2104-8. doi: 10.1016/j.ijporl.2015.09.022. Epub 2015 Sep 28.


Validation of the CORB75 (confusion, oxygen saturation, respiratory rate, blood pressure, and age ≥ 75 years) as a simpler pneumonia severity rule.

Ochoa-Gondar O, Vila-Corcoles A, Rodriguez-Blanco T, Hospital I, Salsench E, Ansa X, Saun N; EPIVAC Study Group.

Infection. 2014 Apr;42(2):371-8. doi: 10.1007/s15010-013-0565-1. Epub 2013 Nov 29.


Ineffectiveness of pneumococcal vaccination in cardiovascular prevention: the CAPAMIS study.

Vila-Corcoles A, Ochoa-Gondar O, Rodriguez-Blanco T, de Diego C, Satue E; EPIVAC Study Group.

JAMA Intern Med. 2013 Nov 11;173(20):1918-20. doi: 10.1001/jamainternmed.2013.6901. No abstract available. Erratum in: JAMA Intern Med. 2013 Nov 25;173(21):2014.


Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in patients with chronic pulmonary diseases: a matched case-control study.

Vila-Corcoles A, Ochoa-Gondar O, Rodriguez-Blanco T, Gutierrez-Perez A, Vila-Rovira A; EPIVAC Study Group.

Hum Vaccin Immunother. 2012 May;8(5):639-44. doi: 10.4161/hv.19466. Epub 2012 May 1.


Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAPAMIS study, one-year follow-up.

Vila-Corcoles A, Ochoa-Gondar O, Rodriguez-Blanco T, Gutierrez-Perez A, Vila-Rovira A, Gomez F, Raga X, de Diego C, Satue E, Salsench E; EPIVAC Study Group.

BMC Public Health. 2012 Mar 22;12:222. doi: 10.1186/1471-2458-12-222.


Invasive pneumococcal disease in Catalonian elderly people, 2002-2009: serotype coverage for different anti-pneumococcal vaccine formulations at the beginning of the new conjugate vaccines era.

Vila-Corcoles A, Ochoa-Gondar O, Gomez-Bertomeu F, Raga-Luria X; EPIVAC Study Group.

Vaccine. 2011 Oct 6;29(43):7430-4. doi: 10.1016/j.vaccine.2011.07.066. Epub 2011 Jul 29.


Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older.

Vila-Corcoles A, Ochoa-Gondar O, Guzmán JA, Rodriguez-Blanco T, Salsench E, Fuentes CM; EPIVAC Study Group.

BMC Infect Dis. 2010 Mar 18;10:73. doi: 10.1186/1471-2334-10-73.


Effects of annual influenza vaccination on winter mortality in elderly people with chronic heart disease.

de Diego C, Vila-Córcoles A, Ochoa O, Rodriguez-Blanco T, Salsench E, Hospital I, Bejarano F, Del Puy Muniain M, Fortin M, Canals M; EPIVAC Study Group.

Eur Heart J. 2009 Jan;30(2):209-16. doi: 10.1093/eurheartj/ehn498. Epub 2008 Nov 8.


Epidemiology of community-acquired pneumonia in older adults: a population-based study.

Vila-Corcoles A, Ochoa-Gondar O, Rodriguez-Blanco T, Raga-Luria X, Gomez-Bertomeu F; EPIVAC Study Group.

Respir Med. 2009 Feb;103(2):309-16. doi: 10.1016/j.rmed.2008.08.006. Epub 2008 Sep 18.


Effect of influenza vaccine status on winter mortality in Spanish community-dwelling elderly people during 2002-2005 influenza periods.

Vila-Córcoles A, Rodriguez T, de Diego C, Ochoa O, Valdivieso A, Salsench E, Ansa X, Badía W, Saún N; EPIVAC Study Group.

Vaccine. 2007 Sep 17;25(37-38):6699-707. Epub 2007 Jul 27.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk